Thursday, May 3, 2007
Hilton Boston Financial District
89 Broad St.
10:00 a.m. EDT
CALGARY, April 5 /CNW/ - NUCRYST Pharmaceuticals Corp. will hold its
Annual General Meeting of Shareholders and Investor Briefing on Thursday,
May 3, 2007 at 10:00 a.m. EDT. The meeting will be held at the Hilton Boston
Financial District, Kellogg Room, 89 Broad Street in Boston. An agenda has
been posted on the NUCRYST website, www.nucryst.com.
Both the meeting and investor briefing will be webcast live at
www.nucryst.com. An audio file of the webcast will be archived and posted on
the NUCRYST website.
NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures
and commercializes medical products that fight infection and inflammation
using its patented atomically disordered nanocrystalline silver technology.
Smith & Nephew plc sell a range of advanced wound care products under their
Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST's
SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also
developing pharmaceutical products to address medical conditions that are
characterized by both infection and inflammation. The Company has developed
its proprietary nanocrystalline silver in a powder form for use as an active
pharmaceutical ingredient, referred to as NPI 32101.
A more detailed discussion of NUCRYST's 2006 year end results can be
found in the 2006 Consolidated Financial Statements and Management's
Discussion and Analysis, which are available at www.sec.gov and www.sedar.com
and in NUCRYST's 2006 Annual Report on Form 10-K, which will be available on
the same websites. NUCRYST filings are also available at
For further information:
For further information: Gillian McArdle, (416) 504-8464,